Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.012

Related search